Quotes for PharmaLundensis AB
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Staffan Skogvall
Chairperson of the Board
- Arne Skogvall
Board
- Bo Wennergren
- Björn Sivik
- Staffan Skogvall
- Stefan Ahlfors
PharmaLundensis is a research company. Main focus is on the treatment of severe pulmonary diseases. The three diseases the company is specialised in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced lung failure. In addition, development is made on system that eliminates the release of pharmaceutical pollution. PharmaLundensis is based in Lund.
CEO
Chairperson of the Board
Board
Name | Capital % | Votes % | Date |
---|---|---|---|
Staffan Skogvall | 50,87 | 50,87 | 2024-04-03 |
Vict Th Engwalls Stiftelse | 2,30 | 2,30 | 2024-03-26 |
Avanza Pension | 1,48 | 1,48 | 2024-03-26 |
Arne Arvidsson | 1,44 | 1,44 | 2024-03-26 |
Nordnet Pensionsförsäkring | 0,75 | 0,75 | 2024-03-26 |
Tommy Johansson | 0,71 | 0,71 | 2024-03-26 |
Staffan Engelbert Bodén | 0,62 | 0,62 | 2024-03-26 |
Arne Skogvall | 0,52 | 0,52 | 2024-03-26 |
Henrik Skog | 0,49 | 0,49 | 2024-03-26 |
Karl-Axel Andersson | 0,49 | 0,49 | 2024-03-26 |
2024-05-16 Delårsrapport 2024-Q1
2024-08-15 Delårsrapport 2024-Q2
2024-11-21 Delårsrapport 2024-Q3
2025-02-20 Bokslutskommuniké 2024